D-dimer concentration was measured with a particle-enhanced, immunoturbidimetric assay in a calibrated SYSMEX7000 analyzer (Sysmex Corporation, Hyogo, Japan). The normal range of morning plasma D-dimer concentration in our hospital laboratory is 0–0.55 mg/L, which is slightly higher than other laboratory (0.25 mg/L [6] (link)). The detection limit was 0.05 mg/L, and the dynamic range was from 0.07 to 35.2 mg/L. The intra-assay coefficient of variation [CV] and inter-assay CV were 1.5–3.4%, 2.6%–4.5%, respectively. Plasma levels of glucose, C-reactive protein (CRP), leucocyte count, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (FBG) were also tested by standard method. For all measurements, levels that were not detectable were considered to have a value equal to the lower limit of detection of the assay.
Sysmex7000 analyzer
The SYSMEX7000 analyzer is a hematology instrument designed for automated blood cell analysis. It provides accurate and reliable measurements of various blood parameters, including red blood cells, white blood cells, and platelets. The SYSMEX7000 is capable of performing a comprehensive blood count and differential analysis, offering essential data for clinical decision-making.
Lab products found in correlation
2 protocols using sysmex7000 analyzer
Plasma Biomarkers in Early COVID-19
D-dimer concentration was measured with a particle-enhanced, immunoturbidimetric assay in a calibrated SYSMEX7000 analyzer (Sysmex Corporation, Hyogo, Japan). The normal range of morning plasma D-dimer concentration in our hospital laboratory is 0–0.55 mg/L, which is slightly higher than other laboratory (0.25 mg/L [6] (link)). The detection limit was 0.05 mg/L, and the dynamic range was from 0.07 to 35.2 mg/L. The intra-assay coefficient of variation [CV] and inter-assay CV were 1.5–3.4%, 2.6%–4.5%, respectively. Plasma levels of glucose, C-reactive protein (CRP), leucocyte count, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (FBG) were also tested by standard method. For all measurements, levels that were not detectable were considered to have a value equal to the lower limit of detection of the assay.
Stroke Risk Factors and Biomarkers
Fasting plasma glucose (FPG) and plasma D-dimer level were measured in the morning after at least 8 h of fasting. Plasma D-dimer level was measured for all patients with a particle-enhanced immunoturbidimetric assay in a calibrated SYSMEX7000 analyzer (Sysmex Corporation, Hyogo, Japan). The normal range of morning plasma D-dimer concentration in our hospital laboratory is 0–0.55 mg/L.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!